Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline (1)
- The ABC Superfamily
- P-Glycoprotein: pioneer and leader
- Structural biology and molecular activity: P-gp
- ABC transporters in the neuro-glio vascular unit
- Role of the ABC proteins at the BMECs?
- Outline (2)
- ABCB and P-gp (ABCB1) at the BBB
- P-glycoprotein: the gatekeeper at the BBB
- P-gp expression in the cerebral vasculature
- Imaging the function of P-gp
- P-glycoprotein at the BBB: quantitative impact
- What have we not learnt from these experiments?
- Brain distribution volume & uptake parameters
- Linear brain uptake flux for morphine & colchicine
- Non-linear brain uptake of a taxoid derivative
- Non-linear brain level of TXD 258
- Brain uptake clearance (Kin) for TXD258 in rodents
- P-gp mediated drug-drug interaction at BBB (1)
- P-gp mediated drug-drug interaction at BBB (2)
- PET imaging P-gp transport activity in humans
- Outline (3)
- ABCG and ABCG2 (BCRP) at the BBB
- Co-immunolocalization of P-gp & BCRP
- BCRP protects against photoxins & protoporphyria
- BBB transport of mitoxantrone by ABCG2
- Expression of ABCG2 in brain cortex & capillaries
- P-gp & BCRP in tandem at BBB: imatinib
- Kinetics of imatinib brain transport at BBB (1)
- Kinetics of imatinib brain transport at BBB (2)
- Influence of Mdr1a & BCRP1 (1)
- Influence of Mdr1a & BCRP1 (2)
- Transport of CGP74588 to the brain
- P-gp & BCRP: two gatekeepers in the BBB
- P-gp & BCRP limit the penetration of topotecan
- Outline (4)
- Where and which MRPs (ABCCs) at the BBB?
- Localization of ABCC transporters in the brain (1)
- Localization of ABCC transporters in the brain (2)
- ABCC transporters at the neuro-glio vascular unit
- Mrp1-mediated efflux at the luminal side
- Lack of Nrp-1-mediated efflux at the luminal side
- Mrp4-mediated efflux at the BBB and BCSFB
- Outline (5)
- Quantitative expression of ABC at the human BBB
- Purity of human brain cortical microvessels
- Relative gene expression of ABC transporters
- Protein amounts in human brain microvessels
- Expression of ABC in human brain microvessels
- Comparing brain microvessels and cortex
- Outline (6)
- Extrapolation (1)
- Questions on interspecies scaling
- ABC differences between in vivo/in vitro BBB
- Efflux ratio = BA/AB
- P-gp efflux ratio for opioids
- Buprenorphine case
- Extrapolation (2)
- Interspecies differences in expression
- Conclusions (1)
- Conclusions (2)
- Conclusions (3)
- The contributors
- Still on the ABC road to better know BBB
Topics Covered
- Introduction to the ABC superfamily and the blood-brain barrier (BBB)
- ABCB and P-glycoprotein (ABCB1) at the BBB
- ABCG and BCRP (ABCG2) at the BBB
- ABCC and the Multi-Drug Resistance Proteins (MRPs) at the BBB
- ABC in isolated human brain microvessels
- Pre-clinical and clinical impact in central nervous system research and drug development
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Scherrmann, J. (2019, February 3). Expression vs. function of ABC transporters at the blood-brain barrier [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 22, 2024, from https://doi.org/10.69645/QNTG2691.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Jean-Michel Scherrmann has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
A selection of talks on Biochemistry
Transcript
Please wait while the transcript is being prepared...
0:00
"Expression versus Function of ABC Transporters at the Blood-Brain Barrier".
I am Jean-Michel Scherrmann,
I am professor of Pharmacokinetics at
the Faculty of Pharmacie of Paris Descartes University.
0:14
During my presentation, I will give
some general properties on the ABC transporters and on the blood-brain barrier.
I will describe P-glycoprotein or ABCB1, BCRP,
or ABCG2, and the multi-drug resistant proteins,
the MRPs at the level of the blood-brain barrier.
In the last part, I will report our data on the gene and
protein expression of this ABC in the human brain microvessels.
And finally, I will conclude my presentation by
the impact that these ABC transporters in the blood-brain barrier can have,
in the research and development of central nervous system drugs.
1:01
The ABC transporters belong to a superfamily with 48 reported genes in humans.
Four subfamilies, A, B, C,
and G contain several isoforms,
which are implied in drug transport.
The most known is a full transporters ABCB1 or P-glycoprotein,
which is mostly expressed in the plasma membrane,
but also in some sub-cellular sites,
like other ABC proteins.
This raises the question of
the ABC transporter role in the intracellular drug disposition.
Nevertheless, the subfamily D, E,
and F do not seem involved in
the transport and expressed at the level of the blood-brain barrier.
Hide